The identification of specific interactions between small molecules and human proteins of interest is a fundamental step in chemical biology and drug development. Here we describe an efficient method to obtain novel binding ligands of human proteins by a chemical array approach. Our method includes large-scale ligand screening with two libraries, proteins and chemicals, the use of cell lysates that express proteins of interest fused with red fluorescent protein, and high-throughput screening by merged display analysis, which removes false positive signals from array experiments. Using our systematic platform, we detected novel inhibitors of carbonic anhydrase II. It is suggested that our systematic platform is a rapid and robust approach to screen novel ligands for human proteins of interest.
Small molecules are used as tools in regulating protein functions of interest. Discovery of them has become a more important step due to increasing information on the human genome and proteome. 1, 2) Chemical arrays represent one of the most promising and high-throughput approaches to searching ligands against proteins of interest. [3] [4] [5] [6] Several successful results from chemical arrays have been reported. 7, 8) One of the key steps in the technology is immobilization of small molecules on a solid surface. Selective coupling approaches have been developed and, are used in the immobilization of small molecules on glass slides, as reported by several groups. 3, 9) On the other hand, we have developed a nonselective immobilization method that makes possible the introduction of a variety of small molecules to solid surfaces. 6, 10) This platform depends on photo-generated carbene species that can crosslink a variety of small molecules onto a solid surface in a functional group-independent manner.
11 ) The methods of immobilization of small molecules have been improved, but prior strategies rely on incubation with a purified protein of interest. To resolve the problem, Bradner and co-workers established a robust chemical array platform with mammalian cell lysates. 12) This method made possible the detection of interactions with a broad range of binding affinity using epitope-tagged or chimeric fluorescent proteins without purification. The use of cell lysates instead of purified proteins is motivated by the facts that the mammalian proteins expressed in mammalian cells are properly modified, [13] [14] [15] are folded as active forms in the presence of co-factors, and, are prepared easily.
Carbonic anhydrases (CAs) are ubiquitous zinc proteins 16) present in prokaryotes to eukaryotes. 17) They are involved in crucial physiological process connected with respiration and the transport of CO 2 /bicarbonate. Among them, CAII has high catalytic activity of CO 2 hydration. 16) CA inhibitors have been reported to serve as antiglaucoma drugs. Moreover, it has been reported that CA inhibitors might serve as anti-cancer, anti-infective drugs and as a novel therapy for Alzheimer's disease. 16, 18) At least 25 CA inhibitors have been reported to be clinically used drugs. Hence the discovery of new CA inhibitors and, establishment of novel uses of these inhibitors have been disirable for clinical application.
In this report, we describe the establishment of a systematic, large-scale chemical array method that can detect specific interactions of small molecules with human proteins of interest. As compared with our previous technology, the immobilization of small molecules in a functional group-independent manner, this method has several improved points, including the use of protein lysates of cells that express proteins fused with red fluorescent protein (RFP) from a gene library we constructed, the use of a public natural-products depository system, and the high-throughput manner by which the merged displaying analysis removes false positive signals on array experiments. Using the sequential screening strategy, we found novel inhibitors for carbonic anhydrase II, suggesting that the method should yield a method of searching for ligands of human proteins of interest.
Materials and Methods
Cloning of human cDNAs and establishment of GLORIA. The target genes were cloned by PCR from a cDNA library of cultured human cell lines, such as HeLa cells, and the obtained fragments were inserted into pGEM-T-Easy vector (Promega, Medison, Wl). The vectors were digested by several restriction enzymes, and the fragments were subcloned into the pDsRed-Express-N1 or pDsRed-Monomer-N1 (Clontech, Mountain View, CA) vector. The sequences were confirmed using the dideoxynucleotide chain termination procedure with an automated sequencer (Applied Biosystems, Foster City, CA). This gene library was named GLORIA (Gene Library of Osada Laboratory at RIKEN for chemical array analysis). GLORIA contains 100 human genes listed in Table 1 . The vectors, pDsRed-Express-N1 and pDsRed-Monomer-N1, encoded DsRed-Express and DsRed-Monomer respectively. 19, 20) DsRed-Express, a variant of Discosoma sp. red fluorescent protein (DsRed), forms a homo-tetramer. On the other hand, DsRedMonomer is a monomeric mutant of DsRed. In this report, the fused proteins expressed from pDsRedExpress-N1 and from pDsRed-Monomer-N1 are designated as RFP-protein and mRFP-protein respectively.
Preparation of mammalian cell lysates that express RFP-fused proteins of interest. HEK293T cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum in a humidified atmosphere containing 5% CO 2 . RFP-fused protein-expressing cells were created by transfecting the plasmids from GLORIA into exponentially growing HEK293T cells using Effectene Transfection Reagent (Qiagen, Tokyo, Japan). After transient transfection for 24 h, the cells were washed, harvested, suspended in PBS, and lysed by sonication. The lysates were centrifuged at 15,000 rpm for 15 min, and the amount of protein in each lysate was measured with Coomassie Brilliant Blue G-250 (BioRad, Hercules, CA). Overexpression of the RFP-fused protein was confirmed using a fluorescence scanner (Amersham Biosciences, Foster City, CA), or by Western blotting.
Preparation of photo-crosslinked chemical arrays. The slides were prepared according to our previous reports. 6) A solution of the compounds (10 mM in DMSO) from NPDepo was immobilized onto PALC (photo-affinity-linker coated) glass slides with a highprecision arrayer that was loaded with 16 micro-spotting pins. Then the slides were exposed to UV irradiation of 4 J cm À2 at 365 nm using a CL-1000L UV crosslinker (UVP, CA) with the compounds. They were rinsed with DMSO, washed successively with DMSO, DMF, THF, DMSO, and Milli-Q water (1 h each), and dried. The slides were degassed and stored at À20 C until use.
Merged display analysis. Glass slides were incubated for 1 h at 4 C with cell lysates that overexpressed RFPfused proteins of interest or cell lysates that overexpressed RFP (3-7 mg protein/ml). After incubation, the slides were washed 3 times in PBS, dried, and scanned at 532 nm on a GenePix microarray scanner (Amersham Biosciences). The fluorescence signals were quantified with GenePix 5.0 software. The images from each slide, one was treated with cell lysates that overexpressed RFP as control and the other was incubated with cell lysates that overexpressed target proteins fused with RFP, were painted green and red respectively using Photoshop 5.5 software. Then, the colored figures were merged. The false positive signals that were caused by binding of ligands to RFP or by autofluorescent signals of the ligand itself were detected as yellow signals.
Isothermal calorimetry and CAII enzyme assay. Isothermal calorimetry (ITC) experiments were done at 25 C using MicroCal VP-ITC (MicroCal, MA). A solution of carbonic anhydrase (Sigma-Aldrich) was degassed for 3 min and then loaded into a calorimeter cell. A Tris-SO 4 buffer (pH 8.4) containing DMSO 4% (v/v) and ligand (5 mM) was degassed for 3 min before use, and then titrated with the protein (50 mM) in the same buffer. After an initial dummy injection of 2 ml, the injection (10 ml) of ligand solution into the calorimeter cell was done. The resulting titration curves were then processed and fitted with Origin 7 software (MicroCal). The inhibitory activity of the compounds for CAII was measured with 4-nirtophenylacetate as substrate, which made possible detection of the esterase activity of the enzyme. 21, 22) Ligands and CAII solution (final, 50 nM) were pre-incubated together for 10 min in 50 mM Tris-SO 4 buffer (pH 8.4). After the addition of a solution containing 10 mM 4-nirtophenylacetate, the reaction was started. It was monitored with a Wallac ARVOSX plate reader at 405 nm (Perkin Elmer, Turku, Finland). The rates of non-enzymatic hydrolysis were subtracted from all observed data. The IC 50 values were calculated from independent triplicate experiments.
General synthesis. Compounds 5-6 and 8-17 were synthesized per a previous report for the synthesis of cinnamoylthiourea derivatives. 23) A solution of ammonium thiocyanate (1 eq.) in acetone (30 ml) was refluxed for 15 min, and the appropriate chloride (e.g., cinnamoyl chloride derivatives) (1.2 eq.) was added to the mixture. After the mixture was refluxed for 15 min, the appropriate amine (e.g., sulfanilamide, 4-aminobenzamide or sulfamethoxypyridazine) (1.2 eq.) was added, and the mixture was stirred for 1 h, cooled, and poured into ice water, and the separated solid was filtered and washed with H 2 O, Et 2 O. The structures were obtained by 1 H NMR and mass spectra using NMR spectrometer JEOL V4.0 (JEOL, Tokyo)(400 MHz) and mass spectrometer JREOL SX-102A by fast bombardment ionization (FAB). The spectra are presented in ''Compound characterization.'' Compounds 4 and 7 were purchased from ChemBridge (San Diego, CA) and 18 and 19 were purchased from Sigma-Aldrich (St. Lous, MO). 
Results

Development of a systematic chemical array method of searching novel ligands
To screen a tremendous number of combinations of compounds and human proteins, we designed a systematic ligand-screening strategy using a chemical array that relied on two original libraries, the GLORIA gene library, and the NPDepo (RIKEN Natural Products 
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Merged display analysis Depository) chemical library (Fig. 1) . To use GLORIA in connection with the robust chemical array system, we cloned 100 genes and designed them to be able to express RFP-fused proteins of interest. HEK293T cells were transfected with vectors that encoded RFP-fused proteins of interest or RFP, and cell lysates were prepared. There are several reasons to use cell lysates instead of purified proteins for high-throughput screening: (i) cell lysates are very easy and fast to prepare, and (ii) target proteins must be folded in their natural conformation and modified properly. 
Identification of rapamycin as an FKBP12-binding protein by this method
NPDepo was established recently by our laboratory.
24)
The compounds from NPDepo were spotted in duplicate onto PALC glass slides 6) so that binding signals and noise could be easily distinguished by comparing duplicate slides. To confirm whether the unique chemical array method can be used in the detection of known interactions, we used 2,011 compounds from NPDepo. Cell lysates that expressed RFP-fused FKBP12 protein and RFP were prepared. After incubation of glass slides with the cell lysates, the images treated with cell lysates that expressed RFP-fused FKBP12 or RFP were colored red and green respectively, and the two images were merged onto a map. We detected rapamycin specifically as an FKBP12-binding ligand from glass slides that were spotted in duplicate with the 2,011 compounds ( Fig. 2A) . To determine whether the signal:noise ration was changed by tetrameric or monomeric RFP, the signal intensities of the slides treated with FKBP12-RFP and FKBP12-mRFP were compared. Although binding signals due to cell lysates expressing FKBP12-RFP and -mRFP were clearly observed, the use of FKBP12-RFP yielded stronger signals. The S/N ratio of a spot treated by FKBP12-RFP was 2-3 fold higher than that of a spot treated by FKBP12-mRFP (Fig. 2B) . Hence we decided to use RFP-fused proteins of interest with our screening system.
Development of GLORIA to be applied to chemical array screening with cell lysates
Next we sought to construct a human gene library, GLORIA, for our platform. We selected many human disease-associated genes, including cancer and glaucoma. We cloned 100 genes and inserted them into pDsRed Express-N1 vector, because the interaction of small molecules with fluorescent protein-fused proteins is very easy to detect ( Table 1 ). The proteins encoded in 1  HPSE  Q9Y251  26  MMP3  P08254  51  ERP27  Q96DN0  76 PARK7  Q99497  2  FKBP1A  P62942  27  ARF6  P62330  52  TXNDC4  Q9BS26  77 CDA  P32320  3  PCBD1  P61457  28  MOCS2  O96033  53  PER1  Q6IN51  78 ASF1A  Q9Y294  4  TIMP1  P01033  29  CDC42EP3 Q9UKI2  54  PSMG2  Q6IAH4  79 ARF1  P84077  5  AGR2  O95994  30  FDPS  P14324  55  NDUFC2  O95298  80 DSTN  P60981  6  RNF34  Q969K3  31  MMP13  P45452  56  TUBA1A  Q71U36  81 MDM2  Q00987  7  PPP6C  O00743  32  TIMP2  P16035  57  TUBG1  P23258  82 DNAJC10  Q8IXB1  8  BCL2L1  Q07817  33  GGPS1  O95749  58  PPME1  Q9Y570  83 PTGS1  P23219  9  MAD2L2  Q9UI95  34  DHFR  P00374  59  ERP29  P30040  84 MED31  Q9Y3C7  10  SFN  P31947  35  BCL2L1   Ã   Q07817-2  60  BLMH  Q13867  85 MYCBP  Q99417  11  S100A4  P26447  36  HIG2  Q9Y5L2  61  TGFA  P01135  86 GLORIA have various functions, such as transferase activity (7%), hydrolase activity, (15%), lyase activity (2%), and non-enzyme proteins (60%). For example, transferases contain protein kinases, which include some clinical therapeutic targets (e.g., aurora kinase B and MEK1). Although many proteins are expressed in fulllength, some were designed to be expressed in truncated forms, such as membrane proteins (e.g., Bcl-xL and Aggrus). Furthermore, many kinds of post-translational modifications occur in the proteins encoded in GLORIA, but if these proteins were expressed by E. coli, they would not be modified. In sum, it appears that the proteins encoded in GLORIA might be useful for our chemical array method. 
Identification of novel ligands for carbonic anhydrase II by the chemical array platform
To obtain novel ligands for CAII, we spotted about 10,000 compounds from NPDepo, and then carried out screening with cell lysates from HEK293T-expressed CAII-RFP. After merged display analysis, we identified two compounds as CAII-binding compounds, 1 and 2, out of 10,000 compounds (Fig. 3A) . To investigate the specificity of 1 and 2 to CAII, we prepared cell lysates of HEK293T cells that expressed 33 different RFPfused proteins (gene numbers 1-33 of GLORIA, Table 1 ), including CAII (no. 15 of GLORIA). Among the 33 proteins tested, 1 (Fig. 3B) and 2 (Fig. 3C) were bound specifically to cell lysates expressed CAII-RFP.
To evaluate the inhibitory activities and binding abilities of 1 and 2 to CAII, we performed an enzyme assay and ITC measurement. The enzyme assay was done in buffer with CAII and 4-nitrophenylacetate as substrates. 21, 22) 1 and 2 showed strong inhibitory activity, the same as acetazolamide, a well-known CAII inhibitor (Fig. 4A) . Moreover, ITC measurements demonstrated that the K d values of 1 and 2 for CA were 159 nM and 508 nM, respectively ( Fig. 4B and C) . On the other hand, compound 3, which lacks the sulfonamide moiety changed to 4,6-dimethylpyrimidine, was not detected by the array analysis. 3 shows very weak inhibitory activity (Fig. 4A ) and has undetectable K d value (data not shown). It has been found that the sulfonamide moiety is very important in inhibiting and interacting with CAII. Taken together with previous CA inhibitor reports, 16, 25) these data strongly suggest that 1 and 2 bound to active site of CAII, and chelated zinc ion in the active site with the sulfonamide moiety. This binding might have resulted in the enzymatic inhibitory effect.
Structure-activity relationship study
To obtain more potent inhibitors of CAII, we synthesized compounds 5-6 and 8-17, and purchased 4, 7, 18, and 19 ( Fig. 5A and B) . The meta-position of sulfonamide moieties on the phenyl ring (5) resulted in a loss of potency against CAII as compared with the paraposition (2). Compounds 15 and 16 lacked sulfonamide moieties on R 2 , which are thought to be an important group for interaction with the zinc ions of enzymes. 25) As expected, the inhibitory activities of 15 and 16 for CAII dramatically decreased. Although modification of R 1 appeared to be tolerant of inhibitory activity, 18 and 19 showed weak inhibitory activities. When exploring variations at the R 1 position, we found that 17 showed the strongest inhibitory activity among the derivatives tested and had strong binding affinity, with a K d value of 66 nM (Fig. 5C ).
Discussion
Although chemical arrays represent one of the most promising and high-throughput approaches to searching ligands against proteins of interest, the discovery of novel interactions between proteins and small molecules using chemical arrays has been limited. 7, 8, 26, 27) It has been reported that the ratio is one hit per 120,000 compounds for enzyme inhibitors. 28) Hence efficient screening of a tremendous number of combinations of proteins and small molecules is necessary.
Matsuyama et al. have reported a large-scale study of the fission yeast Schizosaccharomyces pombe based on cloning of the ORFeome. 29 ) Their system has made it possible to screen for ligands to yeast proteins in a large-scale manner, and it can be applied to the chemical array screening method. However, some proteins associated with human diseases have potential as drug targets, and they are expressed only in mammalian cells (cf. growth factors). In this study, we established that GLORIA contained 100 genes many of which play important roles in human diseases. We also recognized that GLORIA and NPDepo are not definitive. For example, the current number of compounds and proteins in the libraries described here is not sufficient to cover the vast interactions between proteins of interest and small molecules. Cloning of 100 genes is nothing extraordinary in modern molecular biology, and hence we are trying to increase the number of genes and proteins in GLORIA and NPDepo.
In summary, our screening method can perform large-scale chemical array screening in combination with a gene library, GLORIA, and a chemical library, NPDepo. The development of CAII inhibitors indicates the utility of our screening method in the identification of useful ligands to human protein. To discover of these ligands for human proteins, the numbers of genes in GLORIA and of compounds in NPDepo must be increased. This should help to remove one of the bottlenecks to in the discovery of useful tools for modern chemical biology studies and drug discovery research.
